Eric Dein ejdein1
4 years 11 months ago
Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA @RheumNow. https://t.co/APPlumeUtA
k dao KDAO2011
4 years 11 months ago
The FAST trial had 33% of pts with CVD and pts w/class III/IV CHF were not allowed in this study (vs. CARES trial where all subjects had baseline CVD); I am still cautious prescribing febuxostat to pts who have severe CVD until we have more data. @RheumNow https://t.co/fJ9bLcXpR2
Eric Dein ejdein1
4 years 11 months ago
#ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/3Faj64rBjd
sheila RHEUMarampa
4 years 11 months ago
Large cohort of older RA pts newly rx w/HCQ or MTX:
👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ.
@RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/ZnDuMhTMYF
Dr. Rachel Tate uptoTate
4 years 11 months ago
"The goal of a vaccine is not just to protect a (vaccinated) individual, but to end the pandemic." Dr. Dan Barouch #ACR20 @RheumNow
sheila RHEUMarampa
4 years 11 months ago
HCQ not associated with ⬆ incidence of cardiac dse in this cohort of RA pts.
We should continue using it. Benefits >>>risks.
@RheumNow #ACR20 abs1999 https://t.co/zYpbX0CsR1
Dr. John Cush RheumNow
4 years 11 months ago
Industry Abstract Previews - #ACR20
https://t.co/IiF0Md8XXk https://t.co/7qmqwQcgOa
Osteoarthritis Studies: Dr. Janet Pope
Dr. Janet Pope reviews #1650, #1652, #1656 and #1649 at the 2020 ACR annual meeting.
Dr. Rachel Tate uptoTate
4 years 11 months ago
What a great interview with @IreneBlancoMD regarding equity and inclusion in rheumatology. She is amazing! Such an important topic for all of us! #ACR20 @rheumnow https://t.co/cmRfXVGGDJ
Equity and Inclusion in Rheumatology Education: Dr. Irene Blanco
Dr. Irene Blanco discusses diversity and inclusion issues, specifically in rheumatology education, along with the activities and resources available via the Equity and Inclusion Hub, at the 2020 ACR annual meeting.
Dr. John Cush RheumNow
4 years 11 months ago
Listen to part IIII of our #ACR20 Day 3 recap. Follow the link below or find us on Apple podcasts.
https://t.co/cI9UGyFwIJ https://t.co/NiTeNxsGaD
Bella Mehta bella_mehta
4 years 11 months ago
We as young physicians should start paying attention to our contracts-🤦♀️ takeaways
1-know your worth (see MGMA compensation yearly)
2-malpractive/ tail coverage
3-non-compete
4-termination clause
5-gurantee
@RheumNow #ACR20 #5M036
Dr. John Cush RheumNow
4 years 11 months ago
RheumNow’s expanded coverage of the #ACR20 annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Enthesitis in PsA: Dr. Robert Chao
Dr. Robert Chao reviews abstracts #1853, #1552, #1543 and #2021 presented at the 2020 ACR annual meeting.
Robert B Chao, MD doctorRBC
4 years 11 months ago
Gender disparity in Ankylosing Spondylitis symptoms.
1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use
2⃣HLA-B not associated w/ enthesitis
@RheumNow #ACR20 Abs#1872 https://t.co/bxiNUjY1Xh
Poster Hall